• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用激光显微切割和精确质量及时间标签蛋白质组学鉴定人肝内胆管癌的细胞靶标。

Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics.

机构信息

Unité 785, INSERM, Villejuif, France.

出版信息

Mol Cell Proteomics. 2010 Sep;9(9):1991-2004. doi: 10.1074/mcp.M110.000026. Epub 2010 May 31.

DOI:10.1074/mcp.M110.000026
PMID:20513801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2938110/
Abstract

Obtaining accurate protein profiles from homogeneous cell populations in heterogeneous tissues can enhance the capability to discover protein biomarkers. In this context, methodologies to access specific cellular populations and analyze their proteome with exquisite sensitivity have to be selected. We report here the results of an investigation using a combination of laser microdissection and accurate mass and time tag proteomics. The study was aimed at the precise determination of proteome alterations in intrahepatic cholangiocarcinoma ICC, a markedly heterogeneous tumor. This cancer, which is difficult to diagnose and carries a very poor prognosis, has shown an unexplained increase in incidence over the last few years. Among a pool of 574 identified proteins, we were able to report on altered abundance patterns affecting 39 proteins conforming to a variety of potential tumorigenic pathways. The reliability of the proteomics results was confirmed by Western blot and immunohistochemistry on matched samples. Most of the proteins displaying perturbed abundances had not yet been described in the setting of ICC. These include proteins involved in cell mobility and actin cytoskeleton remodeling, which may participate in the epithelial to mesenchymal transition, a process invoked in migration and invasion of cancer cells. The biological relevance of these findings was explored using a tissue microarray. An increased abundance of vimentin was thus detected in 70% of ICC and none of the controls. These results suggest that vimentin could play a role in the aggressiveness of ICC and provide a basis for the serious outcome of this cancer.

摘要

从异质组织中的同质细胞群中获取准确的蛋白质谱,可以提高发现蛋白质生物标志物的能力。在这种情况下,必须选择能够获取特定细胞群并以极高的灵敏度分析其蛋白质组的方法。我们在此报告了使用激光显微切割和精确质量和时间标记蛋白质组学相结合的研究结果。该研究旨在精确确定肝内胆管癌(ICC)的蛋白质组改变,ICC 是一种明显异质的肿瘤。这种癌症难以诊断,预后极差,近年来发病率却呈上升趋势,原因不明。在鉴定出的 574 种蛋白质中,我们能够报告影响 39 种蛋白质丰度变化的模式,这些蛋白质涉及多种潜在的致癌途径。Western blot 和匹配样本的免疫组织化学验证了蛋白质组学结果的可靠性。大多数显示丰度变化的蛋白质在 ICC 中尚未被描述过。这些蛋白质包括参与细胞迁移和肌动蛋白细胞骨架重塑的蛋白质,它们可能参与上皮细胞向间充质转化过程,这是癌细胞迁移和侵袭过程中所涉及的过程。使用组织微阵列探索了这些发现的生物学相关性。在 70%的 ICC 中检测到波形蛋白的丰度增加,而在对照组中则没有。这些结果表明,波形蛋白可能在 ICC 的侵袭性中起作用,并为这种癌症的严重后果提供了依据。

相似文献

1
Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics.应用激光显微切割和精确质量及时间标签蛋白质组学鉴定人肝内胆管癌的细胞靶标。
Mol Cell Proteomics. 2010 Sep;9(9):1991-2004. doi: 10.1074/mcp.M110.000026. Epub 2010 May 31.
2
Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.基于 iTRAQ 的定量蛋白质组学分析鉴定 TPD52 和 DNAJB1 为胆管癌的两种新型胆汁生物标志物。
Oncol Rep. 2019 Dec;42(6):2622-2634. doi: 10.3892/or.2019.7387. Epub 2019 Oct 23.
3
A high level of integrin α6 expression in human intrahepatic cholangiocarcinoma cells is associated with a migratory and invasive phenotype.人肝内胆管癌细胞中高表达整合素α6 与迁移和侵袭表型相关。
Dig Dis Sci. 2013 Jun;58(6):1627-35. doi: 10.1007/s10620-012-2524-6. Epub 2013 Jan 11.
4
FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.法尼醇X受体通过抑制白细胞介素-6诱导的上皮-间质转化,在肝内胆管癌中发挥转移抑制作用。
Cell Physiol Biochem. 2018;48(1):158-172. doi: 10.1159/000491715. Epub 2018 Jul 12.
5
Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma.蛋白质组学分析鉴定 TPI1 为预测肝内胆管癌复发的新型生物标志物。
J Gastroenterol. 2020 Dec;55(12):1171-1182. doi: 10.1007/s00535-020-01729-0. Epub 2020 Oct 21.
6
Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma.脂肪酸结合蛋白 5 促进人肝内胆管癌的细胞增殖和侵袭。
Oncol Rep. 2012 Oct;28(4):1283-92. doi: 10.3892/or.2012.1922. Epub 2012 Jul 19.
7
[Proteomic analysis of serum and serum exosomes, and their application in intrahepatic cholangiocarcinoma].血清及血清外泌体的蛋白质组学分析及其在肝内胆管癌中的应用
Se Pu. 2021 Nov;39(11):1191-1202. doi: 10.3724/SP.J.1123.2021.04009.
8
miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.微小RNA-204通过靶向肝内胆管癌细胞中的蛞蝓样蛋白抑制上皮-间质转化
Cell Physiol Biochem. 2013;32(5):1331-41. doi: 10.1159/000354531. Epub 2013 Nov 22.
9
Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues.基于液相色谱-质谱联用的手术切除的人胆管癌组织差异蛋白质组学研究
J Proteome Res. 2009 Aug;8(8):4092-103. doi: 10.1021/pr900468k.
10
ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.ZEB1表达与肝内胆管癌的预后相关。
J Clin Pathol. 2016 Jul;69(7):593-9. doi: 10.1136/jclinpath-2015-203115. Epub 2015 Dec 15.

引用本文的文献

1
Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches.通过组学和多组学方法揭示肝内胆管癌的异质性
Cancers (Basel). 2024 Aug 20;16(16):2889. doi: 10.3390/cancers16162889.
2
Septin 9 expression regulates 'don't eat me' signals and identifies an immune-epithelial class of intrahepatic cholangiocarcinoma.Septin 9 的表达调控“别吃我”信号,并鉴定出一类具有免疫上皮表型的肝内胆管癌。
Mol Oncol. 2024 Oct;18(10):2369-2392. doi: 10.1002/1878-0261.13673. Epub 2024 Jul 31.
3
Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An study.熊去氧胆酸抑制上皮-间质转化,抑制胆管癌细胞的侵袭性:一项研究。
Oncol Lett. 2022 Oct 26;24(6):448. doi: 10.3892/ol.2022.13568. eCollection 2022 Dec.
4
In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma.原位检测脂质作为肝内胆管癌诊断和预后的潜在生物标志物。
Cancer Manag Res. 2022 Sep 26;14:2903-2912. doi: 10.2147/CMAR.S357000. eCollection 2022.
5
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients.蛋白质组学分析鉴定出意大利肝内胆管癌患者中失调的代谢和氧化相关蛋白。
BMC Cancer. 2021 Jul 28;21(1):865. doi: 10.1186/s12885-021-08576-z.
6
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker.基于质谱的福尔马林固定、石蜡包埋的远端胆管癌分析鉴定出基质血栓调节蛋白-2 作为一种潜在的预后标志物。
J Transl Med. 2020 Sep 4;18(1):343. doi: 10.1186/s12967-020-02498-3.
7
Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma.鉴定四种免疫亚型,其特点是肿瘤微环境的组成和功能明显不同,在肝内胆管癌中。
Hepatology. 2020 Sep;72(3):965-981. doi: 10.1002/hep.31092. Epub 2020 Aug 16.
8
Differential Protein Expression Marks the Transition From Infection With to Cholangiocarcinoma.差异蛋白表达标志着从感染到胆管癌的转变。
Mol Cell Proteomics. 2017 May;16(5):911-923. doi: 10.1074/mcp.M116.064576. Epub 2017 Feb 23.
9
Septin 9 induces lipid droplets growth by a phosphatidylinositol-5-phosphate and microtubule-dependent mechanism hijacked by HCV.Septin 9 通过一种被 HCV 劫持的依赖于磷酸肌醇-5-磷酸和微管的机制诱导脂滴生长。
Nat Commun. 2016 Jul 15;7:12203. doi: 10.1038/ncomms12203.
10
Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.γ-平滑肌肌动蛋白表达与肝细胞癌的上皮-间质转化及干细胞样特性相关。
PLoS One. 2015 Jun 25;10(6):e0130559. doi: 10.1371/journal.pone.0130559. eCollection 2015.

本文引用的文献

1
Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis.基于激光微切割技术对肝硬化发生肝细胞癌的蛋白质组学分析的贡献。
Proteomics Clin Appl. 2007 Jun;1(6):545-54. doi: 10.1002/prca.200600474. Epub 2007 May 11.
2
Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues.基于液相色谱-质谱联用的手术切除的人胆管癌组织差异蛋白质组学研究
J Proteome Res. 2009 Aug;8(8):4092-103. doi: 10.1021/pr900468k.
3
Proteomic analysis of human bile and potential applications for cancer diagnosis.人胆汁的蛋白质组学分析及其在癌症诊断中的潜在应用
Expert Rev Proteomics. 2009 Jun;6(3):285-301. doi: 10.1586/epr.09.12.
4
Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas.
J Hepatol. 2009 Jul;51(1):93-101. doi: 10.1016/j.jhep.2009.03.017. Epub 2009 Apr 25.
5
IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis.癌症中的IQGAPs:一类参与肿瘤发生的支架蛋白家族。
FEBS Lett. 2009 Jun 18;583(12):1817-24. doi: 10.1016/j.febslet.2009.05.007. Epub 2009 May 9.
6
A toolbox for validation of mass spectrometry peptides identification and generation of database: IRMa.用于质谱肽鉴定验证和数据库生成的工具箱:IRMa。
Bioinformatics. 2009 Aug 1;25(15):1980-1. doi: 10.1093/bioinformatics/btp301. Epub 2009 May 6.
7
Serum and bile biomarkers for cholangiocarcinoma.胆管癌的血清和胆汁生物标志物。
Curr Opin Gastroenterol. 2009 May;25(3):279-84. doi: 10.1097/mog.0b013e328325a894.
8
Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue.
Hepatobiliary Pancreat Dis Int. 2009 Apr;8(2):193-200.
9
Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe.上皮-间质转化:癌症研究者亦敌亦友的概念。
Am J Pathol. 2009 May;174(5):1588-93. doi: 10.2353/ajpath.2009.080545. Epub 2009 Mar 26.
10
Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia.全组织及显微切割胰腺导管腺癌的联合基因表达分析鉴定出在肿瘤上皮中特异性过表达的基因。
Hepatogastroenterology. 2008 Nov-Dec;55(88):2016-27.